Release of endothelial microparticles in vivo during atorvastatin treatment; a randomized double-blind placebo-controlled study

Thromb Res. 2012 Jan;129(1):95-7. doi: 10.1016/j.thromres.2011.09.027. Epub 2011 Oct 27.
No abstract available

Publication types

  • Letter
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Antigens, CD / blood
  • Atorvastatin
  • Biomarkers / blood
  • Cadherins / blood
  • Cell-Derived Microparticles / drug effects*
  • Cell-Derived Microparticles / immunology
  • Cross-Over Studies
  • Double-Blind Method
  • Endothelial Cells / drug effects*
  • Endothelial Cells / immunology
  • Female
  • Heptanoic Acids / therapeutic use*
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
  • Male
  • Middle Aged
  • Peripheral Arterial Disease / blood
  • Peripheral Arterial Disease / drug therapy*
  • Placebos
  • Pyrroles / therapeutic use*
  • Sweden
  • Thromboplastin / metabolism
  • Time Factors
  • Treatment Outcome

Substances

  • Antigens, CD
  • Biomarkers
  • Cadherins
  • Heptanoic Acids
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Placebos
  • Pyrroles
  • cadherin 5
  • Thromboplastin
  • Atorvastatin